<?xml version="1.0" ?>
<document id="29636477">
  <sentence id="29636477.s0" text="Deregulation of the phosphoinositide 3-kinase (phosphorylation) pathway contributes to the development and progression of tumors.">
    <entity charOffset="47-62" id="29636477.s0.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="122-128" id="29636477.s0.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="29636477.s0.e0" e2="29636477.s0.e1" id="29636477.s0.p0" relation="true"/>
  </sentence>
  <sentence id="29636477.s1" text="Here, we determine that somatic mutations in phosphorylation (44%), phosphatidylinositol 3-kinase signaling (17%), positive regulation of blood vessel endothelial cell migration (15%), and negative regulation of protein phosphorylation (12%) are prevalent and diverse in Chinese breast cancer patients, with 60 novel mutations identified.">
    <entity charOffset="45-60" id="29636477.s1.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="68-107" id="29636477.s1.e1" ontology_id="GO_0014065" text="phosphatidylinositol 3-kinase signaling" type="GO"/>
    <entity charOffset="115-177" id="29636477.s1.e2" ontology_id="GO_0043536" text="positive regulation of blood vessel endothelial cell migration" type="GO"/>
    <entity charOffset="189-235" id="29636477.s1.e3" ontology_id="GO_0001933" text="negative regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="286-292" id="29636477.s1.e4" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="29636477.s1.e0" e2="29636477.s1.e4" id="29636477.s1.p0" relation="true"/>
    <pair e1="29636477.s1.e1" e2="29636477.s1.e4" id="29636477.s1.p1" relation="true"/>
    <pair e1="29636477.s1.e2" e2="29636477.s1.e4" id="29636477.s1.p2" relation="false"/>
    <pair e1="29636477.s1.e3" e2="29636477.s1.e4" id="29636477.s1.p3" relation="true"/>
  </sentence>
  <sentence id="29636477.s2" text="Collectively, these findings advance our understanding of phosphorylation impactful mutations in breast cancer and have important implications for PI3K-targeted therapy in precision oncology">
    <entity charOffset="58-73" id="29636477.s2.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="104-110" id="29636477.s2.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="29636477.s2.e0" e2="29636477.s2.e1" id="29636477.s2.p0" relation="true"/>
  </sentence>
</document>
